Clinical Trial Update: Study of Vedolizumab Following Multiple Intravenous Doses in Patients With Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 trial of Vedolizumab given via multiple intravenous doses in patients with Ulcerative Colitis has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Vedolizumab (vedolizumab)

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED | Results posted: 2014-07-18